ロード中...
Advancing Drug Innovation for Neglected Diseases—Criteria for Lead Progression
The current drug R&D pipeline for most neglected diseases remains weak, and unlikely to support registration of novel drug classes that meet desired target product profiles in the short term. This calls for sustained investment as well as greater emphasis in the risky upstream drug discovery. Ac...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2727960/ https://ncbi.nlm.nih.gov/pubmed/19707561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0000440 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|